Podcasts about Castration

Today Stephanie talks about Iowa Senator Joni Ernst apologizing for saying "We're all gonna die" when asked about Medicare during a town hall meeting. She also pokes fun at HHS Secretary Robert F. Kennedy Jr.'s report which is suspected to be AI generated and sites studies that do not exist. Guest - Jody Hamilton.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

This week, we're heading to the Lone Star State for a story that puts the “fun” in “funeral” and the “what the actual hell” in “criminal justice.” A Texas embalmer allegedly took anatomical revenge on a dead sex offender—and let's just say, the body wasn't the only thing getting stiff that day. It's a tale of postmortem payback, questionable ethics, and the kind of crime scene that makes even seasoned detectives say, “You know what? I'm good.” Grab your gloves—we're going elbow-deep into this one.

Assistant Professor of Law Daniela Alaattinoğlu is the 2025 Nils Klim Laurete for excellent research. In this podcast, Communications Planner Rosa Lampela talks with Alaattinoğlu about her career as a legal scholar. Alaattinoğlu has conducted research on various themes regarding bodily autonomy, explicit consent and data protection in period-tracking apps. In 2025 she received a highly competitive 1.5 M€ research funding from the European Research Council for her project on the Nordic Sámi Truth and Reconciliation Commissions. Alaattinoğlu's key publications include the monograph Grievance Formation, Rights and Remedies: Involuntary Sterilisation and Castration in the Nordics, 1930s–2020s (2023) and the co-edited volume Contesting Femicide: Feminism and the Power of Law Revisited (2019, with Dr Adrian Howe). Alaattinoğlu has also authored a number of high-quality journal articles and book chapters, and she is a co-editor of Retfærd: Nordic Journal of Law and Justice. Alaattinoğlu receives the award for her research into how laws and societies evolve together, how groups mobilise for change, and how law intersectionally includes and excludes individuals and groups. Alaattinoğlu is the first Finnish legal scholar and the first scholar from the University of Turku to receive the award. The Nils Klim award, funded by the Norwegian government, is worth 43 000 euros and conferred by the University of Bergen on June 5th. Transcript: https://www.utu.fi/sites/default/files/public%3A//media/file/interview-with-legal-scholar-daniela-alaattinoglu.pdf

Céline Géraud, accompagnée de la rédaction d'Europe 1, propose chaque midi un point complet sur l'actualité suivi de débats entre invités et auditeurs.Distribué par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

A game changer for sheep on hill grazings? It's very tricky to castrate and tail lambs within 7 days unless lambs are born inbye. Could two new techniques, that allow castration and tailing up to 3 months of age, not only reduce pain levels in lambs, but allow better and easier management on commons and hills? The all-important intake of colostrum and bonding of ewe and lamb can be disrupted by tailing and castrating. Changing timings, so that one or other is carried out when the lamb is older, perhaps alongside other treatments such as vaccination or worming, reduces mismothering, and could be more efficient. The Animal Welfare Committee (AWC) report on tail docking and castration of lambs (2022) recommends that effective anaesthesia and analgesia should be used routinely for castration and tail docking of lambs, when the methods used are likely to cause significant pain. In recent years new equipment that can reduce the pain associated with tailing and castrating have been developed. Numnuts and Clipfitter are now more widely available and have been shown to have welfare benefits when used for tailing and castrating. In Scotland, the Government has allowed these techniques to be used beyond 7 days of age. Here we discuss the two products: techniques, benefits and drawbacks, costs and practicalities for use with lambs and calves. Subscribe to hear more about the project when we report on crofter's experiences of using the products. Related Resources:Watch our webinar recording where we look at how three farmers are using different methods and approaches to tail docking and castration Webinar - Sustainable Sheep Systems - Tail Docking and CastrationTechnical Note (TN679): Castration and Tail Docking of Lambs Using clipfitter in practice:Using Clips for Castration and Tails FAS TV - Tail Docking and Castration in Lambs

A game changer for sheep on hill grazings? It's very tricky to castrate and tail lambs within 7 days unless lambs are born inbye. Could two new techniques, that allow castration and tailing up to 3 months of age, not only reduce pain levels in lambs, but allow better and easier management on commons and hills? The all-important intake of colostrum and bonding of ewe and lamb can be disrupted by tailing and castrating. Changing timings, so that one or other is carried out when the lamb is older, perhaps alongside other treatments such as vaccination or worming, reduces mismothering, and could be more efficient. The Animal Welfare Committee (AWC) report on tail docking and castration of lambs (2022) recommends that effective anaesthesia and analgesia should be used routinely for castration and tail docking of lambs, when the methods used are likely to cause significant pain. In recent years new equipment that can reduce the pain associated with tailing and castrating have been developed. Numnuts and Clipfitter are now more widely available and have been shown to have welfare benefits when used for tailing and castrating. In Scotland, the Government has allowed these techniques to be used beyond 7 days of age. Here we discuss the two products: techniques, benefits and drawbacks, costs and practicalities for use with lambs and calves. Subscribe to hear more about the project when we report on crofter's experiences of using the products. Related Resources:Watch our webinar recording where we look at how three farmers are using different methods and approaches to tail docking and castration Webinar - Sustainable Sheep Systems - Tail Docking and CastrationTechnical Note (TN679): Castration and Tail Docking of Lambs Using clipfitter in practice:Using Clips for Castration and Tails (YouTube)FAS TV - Tail Docking and Castration in Lambs

The government says it will accept the majority of the recommendations in the report it commissioned into jail sentences.   The independent review, led by ex-Conservative justice secretary David Gauke, looked at how to reduce the prison population by 2028. One of its key proposals would see well-behaved inmates only serve a third of their sentences. It would include sex offenders who had agreed to chemical castration.  On the Sky News Daily, Niall Paterson speaks to political correspondent Liz Bates about what is in the plans and what the political ramifications may be for Labour.  Plus, Professor Belinda Winder, who has been evaluating the government's chemical castration pilot, explains what the process involves and how effective it is. Producer: Natalie KtenaEditor: Wendy Parker

The best way to avoid going bald is… castration. Source: https://en.wikipedia.org/wiki/Castration

05-09-25 - BR - FRI - Castration Is Best Way To Avoid Going Bald - SciNews On Kissing w/Celiac DiseaseSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

05-09-25 - BR - FRI - Castration Is Best Way To Avoid Going Bald - SciNews On Kissing w/Celiac DiseaseSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Dr. Rohan Garje shares the updated recommendations for the ASCO guideline on systemic therapy for patients with metastatic castration-resistant prostate cancer. He discusses the systemic therapy options for patients based on prior therapy received in the castration-sensitive and non-metastatic castration-resistant settings. He emphasizes personalizing treatment choices for each individual, considering patient-specific symptoms and signs, treatment-related toxicities, potential drug interactions, cost, and access. He also reviews recommendations on response assessment. The conversation wraps up with a discussion of potential future updates to this guideline, as the guideline transitions into a “living guideline” on mCRPC. Read the full guideline update, “Systemic Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: ASCO Guideline Update”. Transcript This guideline, clinical tools, and resources are available at www.asco.org/genitourinary-cancer-guidelines. Read the full text of the guideline and review authors' disclosures of potential conflicts of interest in the Journal of Clinical Oncology.      Brittany Harvey: Hello and welcome to the ASCO Guidelines Podcast, one of ASCO's podcasts delivering timely information to keep you up to date on the latest changes, challenges and advances in oncology. You can find all the shows, including this one at asco.org/podcasts. My name is Brittany Harvey and today I'm interviewing Dr. Rohan Garje from Miami Cancer Institute Baptist Health South Florida, lead author on, “Systemic Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: ASCO Guideline Update.” Thank you for being here today, Dr. Garje. Dr. Rohan Garje: Absolutely. Thank you so much for having me, Brittany. Brittany Harvey: And then before we discuss this guideline, I'd like to note that ASCO takes great care in the development of its guidelines and ensuring that the ASCO Conflict of Interest Policy is followed for each guideline. The disclosures of potential conflicts of interest for the guideline panel, including Dr. Garje, who has joined us here today, are available online with the publication of the guideline in the Journal of Clinical Oncology, which is linked in the show notes. So then, to start on the content of this guideline, first, could you provide us an overview of the purpose of this guideline update? Dr. Rohan Garje: Sure. So ASCO has guidelines for prostate cancer and the specific guideline which we have updated for metastatic castrate-resistant prostate cancer was originally published in 2014. It's almost a decade. It's been a long time due for an update. Over the last decade, we have seen a lot of advances in the treatment of prostate cancer, specifically with regards to genomic testing, newer imaging modalities, and also the treatment landscape. Now we have newer options based on genomic targets such as PARP inhibitors, we have radiopharmaceuticals, a newer variant of chemotherapy, and also some specific indications for immunotherapy which were not addressed previously. Because all these advances have been new, it was really important for us to make an update. In 2022, we did make a rapid update with lutetium-177, but these additional changes which we have seen made it an appropriate time frame for us to proceed with a newer guideline. Brittany Harvey: Absolutely. It's great to hear about all these advances in the field to provide new options. So I'd like to next review the key recommendations from this guideline. So let's start with the overarching principles of practice that the panel outlined. What are these key principles? Dr. Rohan Garje: As a group, all the panel members came up with some ground rules: What are necessary for all our patients who are being treated for metastatic CRPC? First, the founding aspect was a definition for what is metastatic CRPC. So we defined metastatic CRPC as castrate level of testosterone with evidence of either new or progressive metastatic disease on radiological assessments or patients who have two consecutive rising PSAs in the setting of existing metastatic disease. We also emphasized on the need for germline and somatic testing for patients with metastatic prostate cancer at an earliest available opportunity because it is critical to select appropriate treatment and also right treatment for patients at the right time. And we actually have a concurrent guideline which addresses what genes to be tested and the timing. The other principles are patients should continue to receive androgen deprivation therapy or undergo surgical castration to maintain castrate level of testosterone. Now the key aspect with these guidelines is personalizing treatment choices. As you can see the evolution of treatment options for prostate cancer, the drugs that were initially developed and approved for prostate cancer were primarily in castrate-resistant settings, but now most of these drugs are being utilized in castrate-sensitive. So, when these patients develop castration resistance, the challenges are there are no appropriate particular drug-specific guidelines they meet. So, it's very important for the clinicians to be aware of what treatments have been received so far prior to castration resistance so that they can tailor the treatment to patient specific situations. In addition, prior to choosing a therapy, it is important for the physicians to consider patient specific symptoms or signs, treatment-related toxicities, potential drug interactions, cost, and also access to the drugs. There may be multiple treatment options available for the patients, but for a patient specific scenario, there may be a drug that may be more promising than the others. So, it is important to tailor the drug choices based on patients' unique circumstances. The panel also recommends to early integrate palliative and supportive care teams for symptom management and also discuss goals of care with the patient as each patient may have unique needs and it's important for physicians to address those concerns upfront in the care. The panel also suggests patients to receive RANK ligand inhibitors such as denosumab or bisphosphonates such as zoledronic acid to maintain the bone strength to prevent skeletal-related events. Finally, I would like to also emphasize this point about the lack of randomized clinical trial data for optimal sequencing of therapies for patients with metastatic CRPC. As I previously alluded, we have taken into account all ongoing clinical trials, prior published data, and came up with a format of preferred drugs based on prior treatments and, I think, by following these several clinical principles which I just mentioned, we can optimally choose and utilize best treatments for patients with metastatic CRPC. Brittany Harvey: Absolutely. These principles that you just outlined are important for optimal patient care, and then I want to touch on one of those things. You talked importantly about the treatments received so far. So in the next set of recommendations, the role of systemic therapy was stratified by the prior therapy received in the castration-sensitive and non-metastatic castration-resistant setting. So starting with what does the panel recommend for patients who are previously treated with androgen deprivation therapy alone in these previous settings and whose disease has now progressed to metastatic castration-resistant prostate cancer? Dr. Rohan Garje: There are multiple treatment options based on prior treatment received. So for patients who received only ADT for their castration-sensitive disease, the panel strongly urges to get HRR testing to check for homologous recombinant repair related changes, specifically for BRCA1 and BRCA2 mutations, because we have three studies which have really shown significant clinical benefit for patients who have BRCA1 and BRCA2 mutations with drugs such as the combination of talazoparib and enzalutamide or olaparib with abiraterone or niraparib with abiraterone. Unless we test for those mutations, we'll not be able to give these agents upfront for the patients. In the HRR testing, if patients have HRR alterations but they are in genes which are non-BRCA, the guideline panel recommends to utilize talazoparib and enzalutamide based combination therapies. Now, if they don't have HRR alterations then there are multiple treatment choices available. It could either include androgen receptor pathway inhibitors such as abiraterone with prednisone. We could also consider docetaxel chemotherapy. The alternate choices for androgen receptor pathways include enzalutamide or the newer agents such as apalutamide and docetaxel. So, as you can see there are multiple options available, but the panel definitely emphasizes to test for HRR testing because this gives patients access to more precision therapies at this point. There may be various scenarios where a unique drug may be available for a specific patient situation. For example, patients who have very limited disease burden and may have one or two metastatic lesions, after a multidisciplinary discussion, targeted local therapies such as radiation or potentially surgery could also be offered. In select patients who have very indolent disease where they are castrate-resistant based on slow rising PSA, low-volume disease or asymptomatic disease can consider sipuleucel-T. And in patients who have bone-only metastatic disease, we could also consider radium-223, which is primarily now utilized for patients who have symptomatic bone disease. Brittany Harvey: Great. I appreciate you reviewing all those options and talking about how important it is to tailor treatment to the individual patient. So then the next category of patients, what is recommended for those who have been previously treated with ADT and an androgen receptor pathway inhibitor and whose disease has now progressed to metastatic castration-resistant prostate cancer? Dr. Rohan Garje: So for patients who received ADT along with an androgen receptor pathway inhibitor, which we consider would be a most common cohort because most patients now in castration-sensitive setting are receiving androgen receptor pathway inhibitor. It was different in the past where five or six years back ADT alone was the most common treatment, but fortunately, with enough awareness and education, treatment choices have improved. Patients are now receiving ADT and ARPI as the most common choice of drug. Once again, at this point the panel emphasizes to consider HRR testing in there is enough data for us to suggest that patients who have alterations in the HRR pathway definitely will benefit with the PARP inhibitor. You know the multiple options, but specifically we speak about olaparib. And then if they are HRR-negative, we prefer patients receive agents such as docetaxel or if they are intolerant to docetaxel, consider cabazitaxel chemotherapy, options such as radium-223, and if they have a specific scenario such as MSI-high or mismatch repair deficiency, pembrolizumab could also be considered. The panel also discussed about the role of a second ARPI agent. For example, if patients progressed on one androgen receptor pathway inhibitor, the second androgen receptor pathway inhibitor may not be effective and the panel suggests to utilize alternate options before considering androgen receptor pathway inhibitor. There may be specific scenarios where a second ARPI may be meaningful, specifically, if alternate choices are not feasible for the concern of side effects or toxicities or lack of access, then a potential ARPI could be considered after progression on ARPI, but the panel definitely encourages to utilize alternate options first. Brittany Harvey: Great. Thank you for outlining those options as well for those patients. So then the next category, what is recommended for patients who have been previously treated with ADT and docetaxel? Dr. Rohan Garje: For patients who received ADT and docetaxel and were never treated with androgen receptor pathway inhibitors, the panel again emphasizes on HRR testing. If they have BRCA1 and 2 mutations, the combination therapies of talazoparib with enzalutamide, olaparib with abiraterone, or niraparib with abiraterone are all good choices. If they don't have BRCA mutations but they have other HRR mutations, the panel suggests to potentially utilize talazoparib with enzalutamide. And if they do not have any HRR alterations, the options could include androgen receptor pathway inhibitors such as abiraterone or enzalutamide. I want to emphasize that these are preferred options, but not the only options. As you can see, there are multiple options available for a particular clinical situation - so the ability of the physicians to access particular combinations, the familiarity of those drugs or the patient's unique situation where they have other medications which can potentially interact with a choice of agents. So I think based on access, based on cost and patients' concurrent illness with potential drug interactions can make one particular combination of therapy better over the other options. Brittany Harvey: Absolutely. That's key to keep in mind that access, contraindications, and cost all play a role here. So then the next set of recommendations. What are the key recommendations for patients who have previously been treated with ADT, an androgen receptor pathway inhibitor, and docetaxel who now have mCRPC? Dr. Rohan Garje: Yes. In this group, the options remain, again, broad. We utilize PSMA imaging here specifically and if they are positive on PSMA imaging, lutetium-177 is a good option. If they do not have PSMA-positive disease on PSMA imaging but if they have HRR alterations, olaparib could be utilized. And if they are negative on PSA imaging, they don't have HRR alterations, then alternate options could include cabazitaxel, radium-223. And if they have MSI-high or deficiency in mismatch repair, pembrolizumab could be utilized in this setting. Brittany Harvey: Thank you for outlining those options as well. So then next the panel addressed treatment options for de novo or treatment emergent small cell neuroendocrine carcinoma of the prostate. What are those key recommendations? Dr. Rohan Garje: Yes. This is a very high unmet need group because there are limited clinical trials, especially prospective clinical trials addressing treatment options for this group. Most of our current guidelines are always an extrapolation from lung small cell cancer based guidelines, but the panel recommends to utilize cisplatin or carboplatin along with etoposide as a preferred choice for this group. Also, an alternate option of carboplatin along with cabazitaxel could be considered for this cohort. The panel also encourages participation in clinical trials. There are numerous trials ongoing now in smaller phase studies and I think it's important for patients to consider these trials as well, because this will give them access to newer agents with potential biological targets. In addition to these agents in specific scenarios or potentially case by case basis, because we don't have prospective data, so we have made it as a select case by case basis to consider adding immunotherapy along with platinum-based chemotherapy followed by maintenance immunotherapy, which is currently a standard of care in small cell lung cancer. But the data is so limited in prostate cancer, so the panel suggested that it has to be a case by case basis only. The alternate options also include lurbinectedin, topotecan, tarlatamab upon progression on platinum-based chemotherapy. Brittany Harvey: Yes. It's important to have these recommendations in these unique situations where there is really a lack of data. So then the final set of recommendations I'd like to cover, what does the panel recommend for how clinicians should assess for response while patients are on systemic therapy and what scans are recommended for this response assessment? Dr. Rohan Garje: Yes. Again, this is another strong emphasis of the panel for global assessment of the patients. Traditionally, patients and physicians per se are heavily reliant on PSA as an accurate marker for response. This is in fact true in earlier phases of prostate cancer either in castrate-sensitive setting or localized prostate cancer setting. But as patients evolve into castrate-resistant, we don't want to heavily rely on PSA alone as a marker of response. The panel suggests to incorporate clinical response, radiological response, and also include PSA as a component, but not just rely primarily on PSA. So the panel also suggests that patients should get a bone scan and a CT scan every three to six months while on treatment to assess for appropriate response or for progression. And now one key important aspect, we are all aware about the evolving role of PSMA-based imaging with several of these new agents that are currently available. We do acknowledge these scans definitely have an important role in the care for patients with metastatic prostate cancer. Currently, the utility is primarily to select patients for lutetium-based therapy and also in situations where the traditional scans such as technitium 99 bone scan or CT scan are equivocal, then a PSMA-based imaging can be helpful. Now we are also aware that there are newer studies coming up, prospective data coming up for the role of PSMA-based imaging for response assessment. We are hoping to update the guidelines if we get access to newer data, but currently we have not recommended the utility of PSMA-based imaging for response assessments. Brittany Harvey: Understood. And I appreciate you describing where there is data here and where there's a lack of data to currently recommend. And we'll look forward to future updates of this guideline. Coming back to – at the start you mentioned how much has changed since the last guideline update. So Dr. Garje, in your view, what is the importance of this update and how will it impact both clinicians and patients with metastatic castration-resistant prostate cancer? Dr. Rohan Garje: The updated guidelines are designed to have a significant impact on clinical practice and also patient outcomes by providing clinicians with a comprehensive evidence-based framework for managing patients with metastatic CRPC. And also, by using these guidelines can make informed decisions, can select therapies tailored to patients' unique genomic status, clinical situation, where they are in the course of the cancer based on what they received previously. Also utilizing these guidelines, we can potentially improve patient outcomes, improve survival, and importantly have efficient use of healthcare resources. Brittany Harvey: Absolutely. We're always looking for ways to improve patient outcomes and survival. I want to wrap us up by talking a little bit about the outstanding questions in this field. So earlier you had mentioned about prospective data to come about PSMA PET scans, but what other outstanding questions are there for patients with metastatic castration-resistant prostate cancer? And what evidence is the panel looking forward to for future updates? Dr. Rohan Garje: We do have now rapidly evolving data specifically about the utility of the radiopharmaceutical lutetium-177 prior to chemotherapy. We are hoping that with newer data we can make some changes to the guideline based on that. We are also looking at newer drugs that are coming up in the pipeline, for example, androgen receptor degraders. We are looking at data that might potentially help based on bispecific T-cell engagers and newer radiopharmaceuticals. So I think in the next few years, we will definitely update all the guidelines again. But this time we are trying to do it more proactively. We are following a newer model. We are calling it as ‘living guidelines' where we are actually utilizing week by week updates where we look at the literature and see if there is any potential practice impacting change or publication that comes up. And we are trying to incorporate those changes as soon as they are available. That way patients and practicing physicians can get the latest information available through the guidelines as well. Brittany Harvey: That's great to hear. Yes, we'll await this data that you mentioned to continuously update this guideline and continue to improve patient outcomes for the future. So Dr. Garje, I want to thank you so much for your time to update this guideline. It was certainly a large amount of recommendations, and thank you for your time today, too. Dr. Rohan Garje: Thank you so much for having me here. And it's always nice talking to you. Brittany Harvey: And finally, thank you to our listeners for tuning in to the ASCO Guidelines podcast. To read the full guideline, go to www.asco.org/genitourinary-cancer-guidelines. You can also find many of our guidelines and interactive resources in the free ASCO Guidelines app, which is available in the Apple App Store or the Google Play Store. If you have enjoyed what you've heard today, please rate and review the podcast and be sure to subscribe so you never miss an episode. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.

In 18th-century Russia, the Skoptsy Cult took religious extremism to a whole new level, believing that castration was the key to salvation. It's a wild, dark chapter in history that shows just how far people can go for their beliefs. To watch the podcast on YouTube: https://bit.ly/TheoriesOfTheThirdKindYT - Get instant access to 200+ bonus Audio episodes - Sign up here: https://theoriesofthethirdkind.supercast.com To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

Welcome to BCI Cattle Chat! On this episode the experts answer your listener questions. They start by discussing what age you should castrate calves and what vaccinations could be given. Next, Dr. Brian Lubbers and Dr. Phillip Lancaster discuss feeding heifers and some of the challenges that come along with that. Finally, they discuss average… Continue reading Listener Questions: Castration, Feeding Heifers, Average Daily Gain

John Zmirak-“If you don't Rejoice at the Defeat of the Party of Child Castration, Open Borders, Fentanyl, Treason, Censorship and forced Vaccination, You gotta Check your Loyalty” The Eric Metaxas Show John Zmirak  Mar 06 2025   Other Episodes Big Bad John is back with Eric to discuss Donald Trump's Address to Congress, Ukraine and Zelensky   Charity Mentioned- Food For the Poor https://foodforthepoor.org/ Help us serve the poorest of the poor Food For The Poor began in 1982 in Jamaica. Today, our interdenominational Christian ministry serves the poor in primarily 17 countries throughout the Caribbean and Latin America. Thanks to our faithful donors, we are able to provide food, housing, healthcare, education, fresh water, emergency relief, micro-enterprise solutions and much more. We are proud to have fed millions of people and provided more than 15.7 billion dollars in aid. Our faith inspires us to be an organization built on compassion, and motivated by love. Our mission is to bring relief to the poorest of the poor in the countries where we serve. We strive to reflect God's unconditional love. It's a sacrificial love that embraces all people regardless of race or religion. We believe that we can show His love by serving the “least of these” on this earth as Christ challenged us to do in Matthew 25. We pray that by God's grace, and with your support, we can continue to bring relief to the suffering and hope to the hopeless.   Report on Food For the Poor by Charity Navigator https://www.charitynavigator.org/ein/592174510   -----------------------------------------------------------------------------------------------  John Zmirak makes his weekly appearance and covers current events and shares recent articles available at-   https://stream.org/author/johnzmirak/ Watch Eric Metaxas on Rumble-  https://rumble.com/c/TheEricMetaxasRadioShow  The Eric Metaxas Show- https://metaxastalk.com/podcasts/ Eric Metaxas Show on Apple Podcasts-    https://podcasts.apple.com/us/podcast/the-eric-metaxas-show/id991156680 Check out- Socrates in the City   Find All of John Zmirak Articles at- https://stream.org/author/johnzmirak/ John Zmirak is a senior editor at The Stream and author or co-author of ten books, including The Politically Incorrect Guide to Immigration and The Politically Incorrect Guide to Catholicism. He is co-author with Jason Jones of “God, Guns, & the Government.”   John Zmirak's new book: No Second Amendment, No First  by John Zmirak  Available March 19, 2024 Today's Left endlessly preaches the evils of “gun violence." It is a message increasingly echoed from the nation's pulpits, presented as common-sense decency and virtue. Calls for “radical non-violence” are routinely endowed with the imprimatur of religious doctrine.   But what if such teachings were misguided, even damaging? What if the potential of a citizenry to exercise force against violent criminals and tyrannical governments is not just compatible with church teaching, but flows from the very heart of Biblical faith and reason? What if the freedoms we treasure are intimately tied to the power to resist violent coercion?  This is the long-overdue case John Zmirak makes with stunning clarity and conviction in No Second Amendment, No First. A Yale-educated journalist and former college professor, Zmirak shows how the right of self-defense against authoritarian government was affirmed in both the Old and New Testaments, is implied in Natural Law, and has been part of Church tradition over the centuries.      4 days ago The Brew: Gavin Newsom Throws Bearded ‘Female' Athletes Under the Campaign Bus   4 days ago President Trump Tells Congress: ‘I Don't Make the Natural Law. I Just Enforce It.'   6 days ago The Brew: Will We Choose the Logos or the Antichrist?   1 week ago The Brew: Did Zelensky's Crass Blustering Save America from Future Stupid Wars? Let's Buy That Man a New Piano!   2 weeks ago The Brew: Screwtape Cordially Invites Us to Join Him in the Inferno by the Left Entrance … or the Right   2 weeks ago The Brew: CNN Blandly Reports That Anti-Trump Deep State Spooks May Hand U.S. Secrets to Foreign Powers   2 weeks ago The Brew: RFK, Jr., Says COVID Panic Was an Orchestrated Plan to Establish Totalitarianism   3 weeks ago The Brew: War Party Groupthink Over Ukraine Is Crumbling. Could Peace Break Out Soon?   3 weeks ago The Brew: Did the COVID Panic Wake Up the West and Shatter Leftist Groupthink?   3 weeks ago The Brew: CBS News Tags Along as German Secret Police Terrorize Citizens for Social Media Posts   3 weeks ago Why Do Progressive Christians Like Pope Francis Want to Burn the West Down?   HELP ACU SPREAD THE WORD!  Please go to Apple Podcasts and give ACU a 5 star rating. Apple canceled us and now we are clawing our way back to the top. Don't let the Leftist win. Do it now! Thanks. Also Rate us on any platform you follow us on. It helps a lot. Forward this show to friends. Ways to subscribe to the American Conservative University Podcast Click here to subscribe via Apple Podcasts Click here to subscribe via RSS You can also subscribe via Stitcher FM Player Podcast Addict Tune-in Podcasts Pandora Look us up on Amazon Prime …And Many Other Podcast Aggregators and sites ACU on Twitter- https://twitter.com/AmerConU . Warning- Explicit and Violent video content.   Please help ACU by submitting your Show ideas. Email us at americanconservativeuniversity@americanconservativeuniversity.com   Endorsed Charities -------------------------------------------------------- Pre-Born! Saving babies and Souls. https://preborn.org/ OUR MISSION To glorify Jesus Christ by leading and equipping pregnancy clinics to save more babies and souls. WHAT WE DO Pre-Born! partners with life-affirming pregnancy clinics all across the nation. We are designed to strategically impact the abortion industry through the following initiatives:… -------------------------------------------------------- Help CSI Stamp Out Slavery In Sudan Join us in our effort to free over 350 slaves. Listeners to the Eric Metaxas Show will remember our annual effort to free Christians who have been enslaved for simply acknowledging Jesus Christ as their Savior. As we celebrate the birth of Christ this Christmas, join us in giving new life to brothers and sisters in Sudan who have enslaved as a result of their faith. https://csi-usa.org/metaxas   https://csi-usa.org/slavery/   Typical Aid for the Enslaved A ration of sorghum, a local nutrient-rich staple food A dairy goat A “Sack of Hope,” a survival kit containing essential items such as tarp for shelter, a cooking pan, a water canister, a mosquito net, a blanket, a handheld sickle, and fishing hooks. Release celebrations include prayer and gathering for a meal, and medical care for those in need. The CSI team provides comfort, encouragement, and a shoulder to lean on while they tell their stories and begin their new lives. Thank you for your compassion  Giving the Gift of Freedom and Hope to the Enslaved South Sudanese -------------------------------------------------------- Food For the Poor https://foodforthepoor.org/ Help us serve the poorest of the poor Food For The Poor began in 1982 in Jamaica. Today, our interdenominational Christian ministry serves the poor in primarily 17 countries throughout the Caribbean and Latin America. Thanks to our faithful donors, we are able to provide food, housing, healthcare, education, fresh water, emergency relief, micro-enterprise solutions and much more. We are proud to have fed millions of people and provided more than 15.7 billion dollars in aid. Our faith inspires us to be an organization built on compassion, and motivated by love. Our mission is to bring relief to the poorest of the poor in the countries where we serve. We strive to reflect God's unconditional love. It's a sacrificial love that embraces all people regardless of race or religion. We believe that we can show His love by serving the “least of these” on this earth as Christ challenged us to do in Matthew 25. We pray that by God's grace, and with your support, we can continue to bring relief to the suffering and hope to the hopeless.   Report on Food For the Poor by Charity Navigator https://www.charitynavigator.org/ein/592174510   -------------------------------------------------------- Disclaimer from ACU. We try to bring to our students and alumni the World's best Conservative thinkers. All views expressed belong solely to the author and not necessarily to ACU. In all issues and relations, we hope to follow the admonitions of Jesus Christ. While striving to expose, warn and contend with evil, we extend the love of God to all of his children. ----------------------------------------------------------------------------------------- 

Heaven's Gate wasn't just another doomsday cult—it was a chilling fusion of sci-fi, Christian prophecy, and absolute control that led 39 people to their final, otherworldly exit.IN THIS EPISODE: Following an anonymous tip, police enter a mansion in Rancho Santa Fe, an exclusive suburb of San Diego, California, and discover 39 victims of a mass suicide. The deceased–21 women and 18 men of varying ages–were all found lying peaceably in matching dark clothes and Nike sneakers and had no noticeable signs of blood or trauma. It was later revealed that the men and women were members of the “Heaven's Gate” religious cult, whose leaders preached that suicide would allow them to leave their bodily “containers” and enter an alien spacecraft hidden behind the Hale-Bopp comet. *** PLUS, the creepy true-crime story of two men who were caught trying to steal the body of the 16th President of the United States, Abraham Lincoln. But that is by no means the end of this story full of twists, turns, myths, and conspiracies.CHAPTERS & TIME STAMPS (All Times Approximate)…00:00:00.000 = Heaven's Gate, Part 1 00:01:10.830 = Show Open00:02:53.580 = Heaven's Gate, Part 200:10:00.270 = Heaven's Gate, Part 300:24:29.552 = Heaven's Gate, Part 400:45:19.851 = Stealing Lincoln's Bones00:58:30.720 = Show Close, Verse, and Final ThoughtSOURCES AND RESOURCES FROM THE EPISODE…Episode Page at WeirdDarkness.com (includes list of sources): https://weirddarkness.com/HeavensGate“Heavens Gate” by Rolling Stone: http://bit.ly/WeirdDarkness2D7tbeZ, Ranker: http://bit.ly/weirddarkness2UIsK4O, and History.com: http://bit.ly/WeirdDarkness2G3uqfN“Stealing Lincoln's Bones” by Troy Taylor: https://www.americanhauntingsink.com/stealing-lincolns-bones=====Darkness Syndicate members get the ad-free version. https://weirddarkness.com/syndicateInfo on the next LIVE SCREAM event. https://weirddarkness.com/LiveScreamInfo on the next WEIRDO WATCH PARTY event. https://weirddarkness.com/TV=====(Over time links seen above may become invalid, disappear, or have different content. I always make sure to give authors credit for the material I use whenever possible. If I somehow overlooked doing so for a story, or if a credit is incorrect, please let me know and I will rectify it in these show notes immediately. Some links included above may benefit me financially through qualifying purchases.)= = = = ="I have come into the world as a light, so that no one who believes in me should stay in darkness." — John 12:46= = = = =WeirdDarkness® is a registered trademark. Copyright ©2025, Weird Darkness.=====Originally aired: November 28, 2021

Hey, Comedy Lovers! ✤ Welcome to "Ian Lara" ⭐ Welcome back Adulterers! This week we host the very funny, very lovely, very fantastic Liza Treyger! We discuss who took the the biggest loss Super Bowl weekend, the lore behind Liza's Law & Order inspired podcast, some of Liza's craziest NYC stories, & Liza's life after releasing her Netflix special! All advice is bad advice, please do adult things and put this podcast on in the background.

Happy Valentine's Day! Let's talk about love. Kind of. But not really. Not all actually. Let's instead, talk about how and why we humans have castrated each other and ourselves throughout human history. This one's not for the squeamish. But, I also can't remember laughing this often in any other recent episode! For Merch and everything else Bad Magic related, head to: https://www.badmagicproductions.com 

In Madagascar, 673 rape cases involving minors were recorded in 2023. In January 2024 alone, at least 4 rapes were reported daily according to the Ministry of Justice ... figures that are likely underestimated. Madagascar is also one of the top 10 countries in the world for online child pornography. To tackle this problem, Madagascar has legalised surgical castration against child rapists. But the measure has sparked outrage among several organisations, who denounce the punishment as cruel and an affront to human dignity. Until now, no castrations have yet been carried out, and medical professionals refuse to speak publicly on the subject. Gaëlle Borgia reports.

Biomedical engineer and sex tech entrepreneur Isabella Sandak-Lewin joins Eva Oh on the #teakink Podcast to break down the gaps in medicine's understanding of female sexuality. From the forgotten science of the female orgasm to the struggles of innovating in sex tech, Isabella shares her journey of developing a wearable sex toy and a diagnostic tool for BV. They explore the orgasm gap, cross-dressing, pole dancing at Cambridge, and the link between sexuality and personal freedom. Watch on YouTube: https://youtube.com/evaoh More on Eva Oh: https://eva-oh.com HIGHLIGHTS: Here are the timestamps for the video episode. On some podcast players you should be able to click the timestamp to jump to that time. (00:00) - Welcome. What is #teakink (00:23) - Isabella Sandak-Lewin - Biomedical Engineer and Sex Tech Entrepreneur (01:53) - The Forgotten Interaction of Body, Medicine and Sexuality (05:40) - Medicine Forgot the Female Orgasm (10:15) - The Orgasm Gap (12:40) - Isabella's Wearable Sex Toy (18:13) - Isabella's BV and More Diagnosis Tool (24:40) - Adolescence, Ballet and Eating Disorders (29:30) - Cross-Dressing and How Women and Men are Perceived (34:00) - How Isabella Claimed Her Sexuality (38:35) - Fem Tech and Sex Tech Struggles (40:00) - 'Coming Out' About Sex Tech (45:00) - The Link Between Sexuality and Personal Freedom (50:00) - Pole Dance, Cambridge University and Castration (58:35) - COVID and Saying Yes

In March 1997, 39 members of the Heaven's Gate cult were found dead in a mansion in San Diego, California. They had orchestrated a mass suicide, believing they would ascend to a higher existence aboard an extraterrestrial spacecraft trailing the Hale-Bopp comet. But how did a small spiritual group evolve into a doomsday cult willing to die for their beliefs? The hosts uncover the origins of the group, the influence of its enigmatic leaders Marshall Applewhite and Bonnie Nettles, and the chilling events that led to their tragic end. Through expert analysis, archival audio, and survivor accounts, we explore the psychology of belief, the allure of apocalyptic prophecy, and the devastating consequences of absolute faith.Join us as we delve into one of the most infamous cults in modern history—and the questions that still haunt us today.MESSAGE US www.itscrypticoutthere@gmail.comListen to the podcast SPOTIFYAPPLE PODCASTSMarshall Applewhite's final exit video.https://youtu.be/wdGXDQ_8bSA?si=LoJswWLN9iPfjjWJSquare structure on Mars.https://dailygalaxy.com/2025/02/nasa-image-reveals-wild-square-structure-on-mars-elon-musk-backs-urgent-mission-to-investigate/

HELP FUND CASTRATION MOVIE ii. BEST OF BOTH WORLDS: https://www.kickstarter.com/projects/weardjupiter/castration-movie-anthology-ii-the-best-of-both-worlds PURCHASE CASTRATION MOVIE i. TRAPS: https://louiseweard.gumroad.com/l/castration-movie This episode is about the most important part of trans community: two bitches arguing.

This week, we're in Utah discussing a horrific attack on a wagon train. Then, we'll talk about a serial killer who has traveled across the country, killing and sexually mutilating young men. Buckle up and join us on this dark and twisted ride through the Beehive State. You may now join us on⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Patreon⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ or ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠buy us a ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Cocktail⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. Be sure to subscribe on ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Apple⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and leave a review, or, email us at unitedstatesofmurder@gmail.com Follow us on ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Facebook⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, and⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Twitter⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠!⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Sources: Meadows Massacre, PBS: American Experience, Smithsonian Magazine, American Massacre: The Tragedy at Mountain Meadows, Deseret News, Marty James Shook - Utah DPS, Medium, Unresolved, The I-80 Hitchhiker Murders: Who Killed Wayne Rifendifer & Marty Shook? Music by ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Pixabay⁠⁠⁠⁠⁠⁠⁠⁠

JACKSON, Miss. (WLBT) - Rankin County Rep. Fred Shanks has filed House Bill 1028 that would increase the penalties for statutory rape. “Essentially, if there's a child involved, 13 or younger, and the offender is 17 or older, it's surgical castration,” explained Shanks. It would be a new option for the judge in sentencing, and it would be in addition to their time in jail. “I'm a father, and my daughter is 13, and you know it really hit home when this came up,” noted Shanks. “I think it's the right thing to do. It sends a strong message. And to be honest, if you know this unfortunate event ever happened to my child, the least of their worries would be this bill.” We asked more of you what you think of the proposal. “I don't have no problem with it,” said Karlos King. “Young children, innocent, pure, I don't think it would be a problem with it.” “I'm not opposed to it,” described Angela Jones. “I just think there needs to be some stipulation. I think if it's a repeat pedophile, absolutely.” “That 13-year-old or under has got to live with that for the rest of their lives,” noted Gayla Book, whose daughter was raped at 13. “There's no getting out of it. You know, there's no 10-year limit for them on whether they get to forget about it in 10 years.” Several states have laws on the books allowing for chemical castration as a consequence of certain sex crimes. However, last year, Louisiana was the first to approve surgical castration. Rep. Shanks is hoping it will clear the committee and be brought up for a vote by the full House of Representatives. “I'd be very curious as to who would vote no on it on the House floor,” he added.  

For the first show of 2025, Ben and Celestia go over some of their favorite shows, the highlights and lowlights of the past year, and some stories we never got a chance to tell. Ben discusses the men who recently lost their lives on a Bigfoot hunt, and Celestia goes down a rabbit hole about children supposedly getting sex change operations and how different outlets report on that issue. But first, we kick off with a tour of new year rituals--most of which have to do with food (and we don't mean eating healthy).

CME credits: 1.25 Valid until: 20-12-2025 Claim your CME credit at https://reachmd.com/programs/cme/guideline-recommendations-for-first-line-treatment-intensification-with-parp-inhibitor-combinations-in-patients-with-metastatic-castration-resistant-prostate-cancer/29196/ This online CME activity, presented in collaboration with the National Comprehensive Cancer Network (NCCN®), focuses on translating oncology clinical practice guidelines into practical strategies for treating genitourinary malignancies. Participants will learn how to integrate clinical trial data into guideline-concordant first- and subsequent-line treatment plans for patients with metastatic urothelial cancer (UC), metastatic castration-resistant prostate cancer (mCRPC), and metastatic renal cell carcinoma (RCC). The program highlights the importance of evidence-based approaches and the use of immunotherapy and targeted therapies for advanced genitourinary malignancies. Attendees will also explore emerging data that could influence future treatment guidelines, patient case examples, and insights from international faculty to develop region-specific therapeutic strategies aligned with NCCN recommendations.

This week, the Supreme Court heard oral arguments in U.S. v. Skrmetti, a legal challenge to Tennessee's ban on so-called "gender-affirming care" for minors. How should Christians think about this? How will this case affect our nation? Here's the Point.  Learn more at standingforfreedom.com

Today the Chicks chat about all the backlash from Joe Biden's pardon of Hunter, everything going on with Daniel Penny, and the CIRCUS THEMED Christmas decor at the White House.Visit https://readywise.com and use promo code CHICKS20 at checkout for 20% off your entirepurchase.Support a more relaxed mind and healthy mood with Calm Mood from https://healthycell.com/chicks Use promo code CHICKS for 20% off your first order.Visit https://getdwplus.com/chicks to get 50% off your annual membership automatically- nocode needed!Visit https://nativehydrate.com/chicks to save up to 44% and get free shipping when you tryNativePath Hydrate.

https://linktr.ee/truthstreamhttps://jeffyounger.substack.comhttps://SaveJames.orgJeff's X page https://x.com/JeffYoungerShow$SAVEJAMES CoinElon Musk post https://x.com/SethDillon/status/1860930943944360364/photo/1The Jeff Younger case was a highly publicized custody battle between Texas parents Jeff Younger and Anne Georgulas over their twin children. Litigated between 2018 and 2022, the case attracted national attention as Georgulas claimed one of the children, born as a boy, was a transgender girl, which Younger denied. Custody was ultimately granted to Georgulas, with the dispute reaching the Texas Supreme Court.

WHY? To fulfill mom's woke will To support this ministry financially, visit: https://www.oneplace.com/donate/549/29

WHY? To fulfill mom's woke will

Dr. Ashwin Singh Parihar speaks with Dr. Phillip Kuo, Dr. Andrew Armstrong, and Dr. Ken Herrmann about how 68Ga-PSMA-11 PET can predict response of metastatic prostate cancer following 177Lu-PSMA-617 therapy. The VISION Trial. Quantitative 68Ga-PSMA-11 PET and ClinicalOutcomes in Metastatic Castration-resistant ProstateCancer Following 177Lu-PSMA-617 (VISION Trial). Kuo and Morris et al. Radiology 2024; 312(2):e233460.  

A Brett and Jeff episode! The co-hosts discuss Jeff's recovery from COVID, including musings on mask-wearing fatigue. Jeff opens up about the emotional experience of dropping his son off at college, while both share their struggles with…

Today's podcast features two great monologues for the price of one!Host Mike Slater begins the show by exploring the problems with economic inflation that this country has been dealing with under President Joe Biden. Why do they keep pretending things are so good fiscally when regular Americans are truly struggling?Following that, Mike explores some more legislation that has come out of Minnesota regarding protecting kids from pedophiles. The Left keeps battling this for some reason. Are they in support of pedophilia? You'll want to hear Slater's takes on this important and fiery issue!

Episode 17 delves into news about cocaine sharks, a memorial for a discarded sex doll, and a couple that puts the fun in "funnel." Plus, "News From The Cosmos," "The Masturbation Minute," and a special report about a castration club.

Drunk pond Karen attacks teens; House of Dragon writer's room loves castration; Batman vs. Alice in Wonderland; neighbors fight over not getting invited to Gala; computer tabs help CSI solve case; injuries on the Blob; and somebody gets “hosed down good”.Unlock the BONUS SCENE at improv4humans.com and gain access to every episode of i4h, all ad-free, as well as TONS of exclusive new podcasts delving deeper into improv, the history of comedy, music and sci-fi. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

This weeks episode brings the Doctors Fernandez (@thedoctorsfernandez) who discusses mixed animal clinics, what it takes to work on a kangaroo and an owl, why you should learn to duck faster if you are castrating a bull, and why they are an incredible resource for all the young Pre-Vet Med Idiots out there. Also, Kent and Cory say some stuff, but does anyone really listen when they talk?

In this episode, Marita shares her ideas unlimited entitled Castration Carl. Resources for this episode can be found here: https://drive.google.com/drive/folders/1Aq2JSPOdwIEF8AlZxTiG2cbn08lffnwr?usp=drive_link Like Here by the Owl Podcast on Facebook and Instagram. Have a future topic idea or wish to be a guest on the show? Message us on social media. --- Support this podcast: https://podcasters.spotify.com/pod/show/nikki-fideldy-doll/support

Billabong and the Otis Carey West Up River Collection Presents… The bad news is Swellian Mascot Doinka just had his nuts cut off. The Good news is he's now getting coned 24/7 so he doesn't chew the stitches out of where his balls used to be. But who else is in the firing line for castration? Turns out the Mexican Pipeline, The Olympics at Chopes, the Challenger Series and plenty more are also in danger of losing their figs. Smiv and Deadly discuss why. UTFS!!See omnystudio.com/listener for privacy information.

Learn more about your ad choices. Visit megaphone.fm/adchoices

The Katherine Massey Book Club @ The C.O.W.S. hosts the second study session on Kenneth Wooden's The Children of Jonestown. Wooden was a journalist at the time of the Guyana genocide and wrote extensively about the mass murder during 1978 and 1979. Like Meiers, Wooden is classified as a White Man. Having immersed ourselves into the life and times of the Rev. Jim Jones, we'll seek better answers about how "father" was able to acquire and kill nearly 300 children - most of them classified as black. Last week, Wooden detailed how Rev. Jones utilized a team of White lawyers to study child welfare and guardianship laws. This way he was able to skillfully utilize esoteric aspects of child law to abuse and kidnap with impunity. Horrifically similar to the Racist Hart Women we read about earlier this year, Jim Jones worked to maintain distance and seclusion so that few eyes would have access to what happened to the children of the Peoples Temple. This included the skillful use of words to avoid court appearances, where prying eyes may see something odd that requires asking questions. While Rev. Jones sipped cognac and ate high on the hog, the children of Jonestown ate rice loaded with maggots and castoff powdered milk. They were often too tired to reject the maggots. #BlackBabiesCostLess #TheCOWS15Years INVEST in The COWS – http://paypal.me/TheCOWS Cash App: https://cash.app/$TheCOWS CALL IN NUMBER: 605.313.5164 CODE: 564943#

J.Lo and Ben's divorce seems imminent, Alec and Hilaria Baldwin are joining TLC, Fiona Harvey sues Netflix for outrageous amount of money, the off-season Vanderpump Rules drama is really unpleasant and Larry Nassar is sucking d*ck for protection. And we talk a bit about the 7M TikTok cult documentary. Friend of the show Cap'n Scoot joins Molly while Tiff is on vacation! Get our after show and ad-free episodes LINKS Baby Reindeer updates  Fiona Harvey sues Netflix for $170m Netflix responds to Fiona's Lawsuit Laura Wray (Fiona's first victim) speaks to Piers Morgan Alec Baldwin  Alec Baldwin has announced that his family is filming a reality show for TLC titled “The Baldwins” Trailer for The Baldwins via Alec's Instagram J.Lo and Ben Jennifer Lopez and Ben Affleck are selling their marital home. Divorce imminent. Billie vs. Sandoval & them  Billie Lee alledges she is no longer friends with Sandoval after she tried and failed to host an intervention for him and that his current GF Victoria is ruining his life Kyle Chan and Victoria go on Up and Adam for a live interview Billie Lee takes this recent interview as shots fired and is going to respond with an expose  Larry Nassar  Larry Nassar is paying for safety in prison with sexual favors Follow us on TikTok, Instagram and Twitter Find more of Molly's stuff Find more of Tiffany's stuff

Headline Highlights: Today's episode dives into everything happening this week in true crime. From new cases to updates on existing ones and more. Madeline Deep Dive: https://podcasts.apple.com/us/podcast/10-to-life/id1519456164 Beam: Head to https://www.shopbeam.com/ANNIEELISE and use code ANNIEELISE for an additional 40% off. Don't forget supplies are limited and you can only shop it through my link Follow the podcast on TikTok: https://www.tiktok.com/@serialouslypodcast        Patreon: https://www.patreon.com/annieelise All Social Media Links: https://www.flowcode.com/page/annieelise_      SERIALously FB Page: https://www.facebook.com/SERIALouslyAnnieElise/    Shop the Merch: https://annieelise.com/ About Me: https://annieelise.com/      For Business Inquiries: 10toLife@WMEAgency.com

This is a bad idea.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Hello, 22 years in prison.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In a case that has captivated and horrified the public, Marius Gustavson, a 46-year-old from Norway, has been sentenced to life imprisonment for his role in orchestrating a series of extreme body modifications through an illegal online platform known as "Eunuch Maker." This narrative not only sheds light on the dark corners of body modificationculture but also raises profound questions about mental health, consent, and the limits ofbodily autonomy. Subscribe on your favorite podcasting apps: https://talkmurder.com/subscribeSupport us on patreon: https://patreon.com/talkmurderSee our technology: https://talkmurder.com/gearContent warning: the true crime stories discussed on this podcast can involve graphic and disturbing subject matter. Listener discretion is strongly advised.Fair use disclaimer: some materials used in this work are included under the fair use doctrine for educational purposes. Any copyrighted materials are owned by their respective copyright holders. Questions regarding use of copyrighted materials may be directed to legal [@] Talkocast.com

1. SCOTUS Releases Order List; Won't Hear Elon Musk's SEC Challenge, Will Hear Marijuana-Related RICO Case (0:44)2. Louisiana Sentences Man to 50 Years and Physical Castration; Other States With Castration Laws Too (6:23)3. QUICK HITTERS: Columbia University Gives Protesters Deadline, Trump and DeSantis Meet in Miami, Biden Speaks With Mexico's President About Border, House and Senate Negotiators Agree on $105B Aviation Bill (11:17)Get EXCLUSIVE, unbiased content on Patreon.Watch this episode on YouTube.Follow Jordan on Instagram and TikTok.All sources for this episode can be found here. 

Abortion laws cause birth rates to rise in Texas, the mother of a school shooter is charged, King Charles has cancer, and more in news. Then, Cat Bohannon joins to discuss evolution from a more female perspective, including but not limited to: corkscrew vaginas, castration, and blood sucking demon fetuses. Finally, Sani-Petty (The Brothers Sun, Law and Order, and…boogers-induced Alzheimer's?). For a closed-captioned version of this episode, click here. For a transcript of this episode, please email transcripts@crooked.com and include the name of the podcast. Show NotesCat BohannonEve: How The Female Body Drove 200 Million Years Of Human Evolution  News SourcesAfter Abortion Ban, Texas Teen Birth Rate Rises (Texas Observer)Reproductive Freedom Alliance Urges Supreme Court to Respect Longstanding FDA Authority & Access to Safe Abortion Medication (Press Release)Florida's abortion measure: What to know as it heads to state Supreme Court (News Nation Now)South Dakota tribe bans governor from reservation over US-Mexico border remarks (Fox21 News)King Charles has cancer. Here's what we know — and what we don't (CNN)Gaetz, Stefanik offer resolution declaring Trump ‘did not engage in insurrection' (The Hill)Nikki Haley makes surprise appearance at "Saturday Night Live" town hall (CBS)Erin read the headline and subhead here: Taylor Swift Demands 21-Year-Old Stop Tracking Her Private Jet (Bloomberg)